Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

January-February 2022; Volume 19,Issue 1

Review

  • You have access
    The Application of Bayesian Methods in Cancer Prognosis and Prediction
    JIADONG CHU, NA SUN, WEI HU, XUANLI CHEN, NENGJUN YI and YUEPING SHEN
    Cancer Genomics & Proteomics January 2022, 19 (1) 1-11; DOI: https://doi.org/10.21873/cgp.20298

Articles

  • You have access
    Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction
    JUN YAMAMOTO, YUSUKE AOKI, SACHIKO INUBUSHI, QINGHONG HAN, KAZUYUKI HAMADA, YOSHIHIKO TASHIRO, KENTARO MIYAKE, RYUSEI MATSUYAMA, MICHAEL BOUVET, STEVEN G. CLARKE, ITARU ENDO and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics January 2022, 19 (1) 12-18; DOI: https://doi.org/10.21873/cgp.20299
  • You have access
    Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells
    TANIN ZADEH, MARIANA LUCERO and RAJ P. KANDPAL
    Cancer Genomics & Proteomics January 2022, 19 (1) 19-26; DOI: https://doi.org/10.21873/cgp.20300
  • You have access
    Novel Contribution of Long Non-coding RNA MEG3 Genotype to Prediction of Childhood Leukemia Risk
    JEN-SHENG PEI, WEN-SHIN CHANG, CHAO-CHUN CHEN, MEI-CHIN MONG, SHIH-WEI HSU, PEI-CHEN HSU, YUAN-NIAN HSU, YUN-CHI WANG, CHIA-WEN TSAI and DA-TIAN BAU
    Cancer Genomics & Proteomics January 2022, 19 (1) 27-34; DOI: https://doi.org/10.21873/cgp.20301
  • You have access
    Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells
    DARAPORN CHUA-ON, TANAKORN PROUNGVITAYA, ANCHALEE TECHASEN, TEMDUANG LIMPAIBOON, SITTIRUK ROYTRAKUL, DOUNGDEAN TUMMANATSAKUN, NORIE ARAKI and SIRIPORN PROUNGVITAYA
    Cancer Genomics & Proteomics January 2022, 19 (1) 35-49; DOI: https://doi.org/10.21873/cgp.20302
  • You have access
    SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines
    SO YOUNG CHOI, JU MI JEON, ANN YAE NA, OH KWANG KWON, IN HYUK BANG, YUN-SOK HA, EUN JU BAE, BYUNG-HYUN PARK, EUN HYE LEE, TAE GYUN KWON, JUN NYUNG LEE and SANGKYU LEE
    Cancer Genomics & Proteomics January 2022, 19 (1) 50-59; DOI: https://doi.org/10.21873/cgp.20303
  • You have access
    Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients
    GEORGIOS N. TSAOUSIS, EIRINI PAPADOPOULOU, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, NIKOLAOS TSOULOS, IOANNIS BOUKOVINAS, THEOFANIS FLOROS, RODONIKI IOSIFIDOU, OURANIA KATOPODI, ANNA KOUMARIANOU, CHRISTOS MARKOPOULOS, KONSTANTINOS PAPAZISIS, VASILEIOS VENIZELOS, ACHILLEAS KAPSIMALIS, GRIGORIOS XEPAPADAKIS, AMANDA PSYRRI, EUGENIU BANU, DAN TUDOR ENIU, ALEXANDRU BLIDARU, DANA LUCIA STANCULEANU, ANDREI UNGUREANU, VAHIT OZMEN, SUALP TANSAN, MEHMET TEKINEL, SUAYIB YALCIN and GEORGE NASIOULAS
    Cancer Genomics & Proteomics January 2022, 19 (1) 60-78; DOI: https://doi.org/10.21873/cgp.20304
  • You have access
    Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab
    BASMA M. SHARAF, ALEXANDER D. GIDDEY, HASAN ALNISS, HAMZA M. AL-HROUB, RAAFAT EL-AWADY, MUATH MOUSA, AHMED ALMEHDI, NELSON C. SOARES and MOHAMMAD H. SEMREEN
    Cancer Genomics & Proteomics January 2022, 19 (1) 79-93; DOI: https://doi.org/10.21873/cgp.20305
  • You have access
    Molecular Markers for Long-term Survival in Stage IIIA (N2) NSCLC Patients
    ANCA NASTASE, SIMONA O. DIMA, AUDREY LUPO, VICTORIA LASZLO, REBECCA TAGETT, SORIN DRAGHICI, MONICA ELIA GEORGESCU, ALEXANDRU NECHIFOR, SORIN BERBECE, IRINEL POPESCU, MARCO ALIFANO, WALTER KLEPETKO and MADALINA GRIGOROIU
    Cancer Genomics & Proteomics January 2022, 19 (1) 94-104; DOI: https://doi.org/10.21873/cgp.20306
  • You have access
    High Frequency of Juxtamembrane Domain ERBB2 Mutation in Gastric Cancer
    SUJIN PARK, SOOMIN AHN, DEOK GEUN KIM, HYUNJIN KIM, SO YOUNG KANG and KYOUNG-MEE KIM
    Cancer Genomics & Proteomics January 2022, 19 (1) 105-112; DOI: https://doi.org/10.21873/cgp.20307
Back to top
PreviousNext

In this issue

Cancer Genomics - Proteomics: 19 (1)
Cancer Genomics & Proteomics
Vol. 19, Issue 1
January-February 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction
  • Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells
  • Novel Contribution of Long Non-coding RNA MEG3 Genotype to Prediction of Childhood Leukemia Risk
  • Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells
  • Molecular Markers for Long-term Survival in Stage IIIA (N2) NSCLC Patients
Sign up for alerts

Jump to

  • Review
  • Articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire